A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS)

Efficacy of mesenchymal stem cells (MSCs) for treatment of acute respiratory distress syndrome (ARDS) suggests bioactive bone marrow MSC extracellular vesicles (BM-MSC EVs) may be effective. A patient with severe COVID-19 associated ARDS who was presumed to expire was treated with a BM-MSC EV prepar...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Erik Osborn, John T. Ransom, Anastasiya Shulman, Vikram Sengupta, Mohammed Choudhry, Ali Hafiz, Jacob Gooden, Amy L. Lightner
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Elsevier 2024-01-01
Σειρά:	Respiratory Medicine Case Reports
Θέματα:	Mesenchymal stem cell MSC Extracellular vesicle EV ARDS
Διαθέσιμο Online:	http://www.sciencedirect.com/science/article/pii/S2213007124001102
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!